MedPath
NMPA Approval

Pazufloxacin Mesilate Injection

国药准字H20090341

September 30, 2019

Drug Information

甲磺酸帕珠沙星注射液

注射剂

2ml:0.3g(以C16H15FN204计)

化学药品

September 30, 2019

Company Information

Manufacturing Company

苏州市吴中区东吴南路2-1号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

甲磺酸帕珠沙星注射液 - NMPA 批准文号 | MedPath